期刊文献+

不同常用抗癫痫药对儿童癫痫患者的影响及疗效

下载PDF
导出
摘要 目的探讨常用抗癫痫药丙戊酸钠、左乙拉西坦、奥卡西平对儿童癫痫患者血清叶酸、同型半胱氨酸和血氨水平的影响以及疗效和副作用差异。方法选取2020年6月至2022年6月收治的儿童癫痫患者125例,根据治疗方式不同分为丙戊酸钠组(VPA组,45例)、左乙拉西坦组(LEV组,43例)和奥卡西平组(OXC组,37例),选取同期行健康体检儿童30例作为对照组。比较四组血清叶酸、血氨和同型半胱氨酸水平及三组治疗组的疗效和副作用。结果四组儿童入组时血清叶酸、血氨水平比较,差异有统计学意义(P<0.05)。三组治疗后血氨、同型半胱氨酸水平及治疗总有效率比较,差异有统计学意义(P<0.05)。结论临床治疗儿童癫痫患者考虑到疗效、治疗依从性、副作用和对代谢的影响可优选左乙拉西坦,在使用丙戊酸钠或奥卡西的情况下需关注患者血清叶酸、同型半胱氨酸和血氨水平的变化。 Objective To investigate the effects of commonly used antiepileptic drugs sodium valproate,levetiracetam,and oxcarbazepine on serum folate,homocysteine,and blood ammonia levels,as well as the differences in efficacy and side effects in paediatric epilepsy patients.Methods 125 cases of paediatric epilepsy patients admitted from June 2020 to June 2022 were selected and divided into the sodium valproate group(VPA group,45 cases),the levetiracetam group(LEV group,43 cases)and the oxcarbazepine group(OXC group,37 cases)according to the treatment modality,and 30 cases of children who underwent a physical examination during the same period were selected as the control group.The serum folate,blood ammonia and homocysteine levels of the four groups were compared,as well as the efficacy and side effects of the three treatment groups.Results Comparison of serum folate and blood ammonia levels at the time of enrolment in the four groups of children showed statistically significant differences(P<0.05).Comparison of blood ammonia,homocysteine levels and total effective rate of treatment in the three treatment groups,the difference was statistically significant(P<0.05).Conclusion Clinical treatment of paediatric epilepsy patients considering the efficacy,treatment compliance,side effects and the impact on metabolism can be preferred to levetiracetam,in the case of the use of sodium valproate or oxcarbazepine need to pay attention to the changes in the patient's serum folic acid,homocysteine and blood ammonia levels.
出处 《浙江临床医学》 2024年第9期1342-1344,共3页 Zhejiang Clinical Medical Journal
基金 浙江省台州市科技计划项目(1902ky99)。
关键词 癫痫 抗癫痫药 叶酸 同型半胱氨酸 血氨 Epilepsy Antiepileptic drug Folic acid Homocysteine Blood ammonia
  • 相关文献

参考文献3

二级参考文献65

  • 1田国红,赵忠新.左乙拉西坦——一种具有全新作用机制的抗癫痫新药[J].中国新药与临床杂志,2006,25(10):782-786. 被引量:43
  • 2Bialer M. Chemical properties of antiepileptic drugs (AEDs) [J]. Adv Drug Deliv Rev, 2012, 64 (10) : 887 - 895. 被引量:1
  • 3Nalivaeva NN, Belyaev ND, Turner AJ. Sodium valproate : an old drug with new roles[J]. Trends Pharmacol Sci, 2009,30(10) :509- 514. 被引量:1
  • 4Arroyo S, Sander JW. Carbamazepine in comparative trials:Pharmacokinetic characteristics too often forgotten [J]. Neurology,1999,53(6) :1170 1174. 被引量:1
  • 5Edeki TI, Brase DA. Phenytoin disposition and toxicity role of pharmaeogenetic and interethnie factors[J]. Drug Metab Rev, 1995,27(3) :449 - 469. 被引量:1
  • 6Janz R, Sudhof TC. SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family[J]. Neuroscience, 1999,94 (4) 1279- 1290. 被引量:1
  • 7Yao J,Nowack A, Kensel-Hammes P, et al. Cotraf{icking of SV2 and synaptotagmin at the synapse[J]. J Neurosci, 2010,30(16) :5569 - 5578. 被引量:1
  • 8Janz R, Goda Y, Geppert M, et al. SV2A and SV2B function as redundant Ca+ regulators in neurotransmitter release[J]. Neuron, 1999,24(4) : 1003 - 1016. 被引量:1
  • 9van Vliet EA, Aronica E, Redeker S, et al. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsyLJ]. Epilepsia ,2009,50(3) :422 - 433. 被引量:1
  • 10Lynch BA, Lambeng N, Nocka K, et al. The synaptie vesicle protein SV2A is the binding site for theantiepileptic drug levetiracetam[J]. Proc Nail Acad Sci USA ,2004,101 (26) :9861 - 9866. 被引量:1

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部